93, respectively; P 0 priligy 30 mg Has LFTS within 2 times the upper limit of normal proven by a Comprehensive Metabolic Panel CMP performed within 6 months of protocol enrollment and while the patient was on Tamoxifen, an AI, or ovarian suppression Patients meet criteria for the diagnosis of HSDD as defined by the DSM IV and ISSWSH Consensus paper
93, respectively; P 0 priligy 30 mg Has LFTS within 2 times the upper limit of normal proven by a Comprehensive Metabolic Panel CMP performed within 6 months of protocol enrollment and while the patient was on Tamoxifen, an AI, or ovarian suppression Patients meet criteria for the diagnosis of HSDD as defined by the DSM IV and ISSWSH Consensus paper